Skip to main content
  • Original article
  • Open access
  • Published:

Intra-articular injection of hyaluronic acid for treatment of osteoarthritis knee: comparative study to intra-articular corticosteroids

Abstract

Objective

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Although both corticosteroid and hyaluronic acid (HA) injections are widely used to palliate the symptoms of knee OA, few researches involving a comparison of two interventions have been conducted.

The objective of the study was to compare the efficacy and safety of HA to corticosteroid injections for the treatment of knee OA.

Patients and methods

We enrolled 60 patients with knee OA who were randomized to receive intra-articular injection of either HA or the corticosteroid. The therapy was followed for 6 months. The patients treated with HA received one course of injections per week for 3 weeks and the other group received single injection of corticosteroid. The two groups were compared as regards pain and functional improvement using the Western Ontario and McMaster University Osteoarthritis Index and visual analog scale.

Results

The study included 60 patients, with age ranging from 36 to 65 years with a mean of 51.8 years. All of them were diagnosed with knee OA using ACR clinical classification criteria. Patients were recruited between May and December 2015.

After 6 months of the treatment, both groups showed functional improvement. HA group showed significant improvement compared with the corticosteroid group as regards the Western Ontario and McMaster University Osteoarthritis Index and visual analog scale (P=0.01).

Conclusion

Both HA and corticosteroid groups showed improvement in pain and knee function, but the intra-articular HA was superior to corticosteroid on long-term follow-up. This supports the potential rate of intra-articular HA as an effective long-term therapeutic option for patients with OA of the knee.

References

  1. Jain P, Jain SK. Comparison of efficacy of methylprednisolone and triamcinolone in OA of the knee. Int J Sci Stud 2015; 3:58–62.

    Google Scholar 

  2. Symmons D, Mathers C, Pfleger B. World Health Organization (WHO). Global burden of osteoarthritis in the year 2000. Bulletin of the World Health Organization; 2003. 81 (9).

  3. Fautrel B, Hilliquin P, Rozenberg S, Allaert FA, Coste P, Leclere A et al. Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. Joint Bone Spine 2005; 72:235–240.

    Article  Google Scholar 

  4. Dougados M, Hochberg MC. Management of osteoarthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weismen M, editors. Rheumatology. 5th ed. Philadelphia: Mosby/Elsevier; 2011. pp. 1793–1799.

    Chapter  Google Scholar 

  5. Gorelick L, Rozano-Gorelick A, Robinson D, Marcus O, Jourban S, Ram E. Treatment of hip trochanteric bursitis using hyaluronate injections. Open J Rheumatol Immune Dis 2013; 3:125–129.

    Google Scholar 

  6. Yasuda T. Progress of research in osteoarthritis: pharmacological effects of hyaluronan. Clin Calcium 2009; 19:1644–1652.

    CAS  PubMed  Google Scholar 

  7. Goldring MB, Goldring SB. Osteoarthritis. J Cell Physiol 2007; 213:626–634.

    Article  CAS  Google Scholar 

  8. Kreger ST, Voytik-Harbin SL. Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response. Matrix Biol 2009; 28:336–346.

    Article  CAS  Google Scholar 

  9. Peng H, Zhou JL, Liu SQ, Hu QJ, Ming JH, Qiu B. Hyaluronic acid inhibits nitric oxide-induced apoptosis and differentiation of articular chondrocytes in vitro. Inflamm Res 2010; 59:519–530.

    Article  CAS  Google Scholar 

  10. Conrozier T, Chevalier X. Long-term experience with hyaln GF-20 in treatment of knee osteoarthritis. Expert Opin Pharmacother 2008; 9:1797–1804.

    Article  CAS  Google Scholar 

  11. Bruyere O, Cooper C, Pelletier JP, Branco J, Luies Brandi M, Guillemin F, et al. An algorism recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014; 44:253–263.

    Article  Google Scholar 

  12. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the knee society clinical rating system. Clin Orthop Relat Res 1989; 248: 13–14.

    Google Scholar 

  13. Hochberg LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003; 5:54.

    Article  Google Scholar 

  14. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of non-pharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64:465.

    Article  CAS  Google Scholar 

  15. Uusitalo RR, Vaysbrot EE, Sullivan MC, McAlindon TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2014; 43:593.

    Article  Google Scholar 

  16. Uusitalo H, Salminen H, Vuorio E. Activation of chondrogenesis in response to injury in normal and transgenic mice with cartilage collagen mutations. Osteoarthritis Cartilage 2001; 9(Suppl A):S174.

    PubMed  Google Scholar 

  17. Rutjes AW, Jüni P, Da Costa BR, Trelle S, Nüesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med 2012; 157:180.

    Article  Google Scholar 

  18. Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular acid compared to intra-articular triamcinolone hexaacitonoide in inflammatory knee OA. Osteoarthritis Cartilage 1995; 3:269–273.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mona Hamdy.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elsawy, S.A., Hamdy, M. & Ahmed, M.S. Intra-articular injection of hyaluronic acid for treatment of osteoarthritis knee: comparative study to intra-articular corticosteroids. Egypt Rheumatol Rehabil 44, 143–146 (2017). https://doi.org/10.4103/err.err_55_16

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/err.err_55_16

Keywords